Screener
PROCEPT BioRobotics Corporation PRCT Service — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by PROCEPT BioRobotics Corporation in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: PROCEPT BioRobotics Corporation’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001588978-26-000030
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | $94,498 | $79,182 | $177,631 | $148,344 |
| Cost of sales | 32,119 | 27,436 | 61,304 | 52,437 |
| Gross profit | 62,379 | 51,746 | 116,327 | 95,907 |
| Operating expenses: | ||||
| Research and development | 20,101 | 17,632 | 41,567 | 34,034 |
| Selling, general and administrative | 69,668 | 56,303 | 134,756 | 111,499 |
| Total operating expenses | 89,769 | 73,935 | 176,323 | 145,533 |
| Loss from operations | (27,390) | (22,189) | (59,996) | (49,626) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is PROCEPT BioRobotics Corporation's service — revenue?
- PROCEPT BioRobotics Corporation (PRCT) reported service — revenue of $6.84M in Q2 2026.
- How has PROCEPT BioRobotics Corporation's service — revenue changed year-over-year?
- PROCEPT BioRobotics Corporation's service — revenue increased by 36.1% year-over-year, from $5.02M to $6.84M.
- What is the long-term trend for PROCEPT BioRobotics Corporation's service — revenue?
- Over 4 years (2021 to 2025), PROCEPT BioRobotics Corporation's service — revenue has grown at a 108.8% compound annual growth rate (CAGR), from $1.08M to $20.48M.
- What does service — revenue mean?
- This metric represents the total revenue generated from post-sale service contracts, maintenance, and support activities related to the company's installed base of robotic surgical systems. It serves as a key indicator of the recurring revenue stream and the long-term value derived from the existing customer base after the initial capital equipment sale. Growth in this segment reflects increasing system utilization and the expansion of the company's service-based business model.
Ask your AI about PROCEPT BioRobotics Corporation's service — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude